Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2007 | 03-2007 | 12-2006 | 09-2006 | 06-2006 | |
| Sales | 49,354 | 48,377 | 46,618 | 44,240 | 45,583 |
| Cost of Goods | 30,817 | 33,400 | 30,695 | 32,765 | 33,209 |
| Gross Profit | 18,537 | 14,977 | 15,923 | 11,475 | 12,374 |
| Operating Expenses | 12,827 | 11,440 | 19,122 | 11,460 | 13,710 |
| Operating Income | 6,527 | 3,937 | -2,504 | 780 | -1,127 |
| Other Income | 787 | 767 | 993 | 848 | 546 |
| Pre-tax Income | 7,314 | 4,704 | -1,511 | 1,628 | -581 |
| Income Tax | 2,738 | 1,480 | -747 | 222 | -228 |
| Net Income Continuous | 4,576 | 3,224 | -764 | 1,406 | -353 |
| Net Income | $4,576 | $3,224 | $-764 | $1,406 | $-353 |
| EPS Basic Total Ops | 0.14 | 0.10 | -0.02 | 0.04 | -0.01 |
| EPS Basic Continuous Ops | 0.14 | 0.10 | -0.02 | 0.04 | -0.01 |
| EPS Diluted Total Ops | 0.14 | 0.10 | -0.02 | 0.04 | -0.01 |
| EPS Diluted Continuous Ops | 0.14 | 0.10 | -0.02 | 0.04 | -0.01 |
| EBITDA(a) | $10,741 | $8,071 | $1,722 | $4,627 | $2,669 |